Dashboard
Manage Tickers

VYNE VYNE Therapeutics Inc.

Nasdaq vynetherapeutics.com


$ 0.34 $ -0.01 (-2.67 %)    

Monday, 03-Nov-2025 15:59:53 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.78 $ -3.11 (-0.49 %)
DIA $ 472.70 $ -2.66 (-0.56 %)
SPY $ 681.88 $ -2.29 (-0.33 %)
TLT $ 89.68 $ 0.07 (0.08 %)
GLD $ 366.72 $ 0.05 (0.01 %)
$ 0.3462
$ 0.36
$ 0.34 x 10
$ 0.39 x 30,000
$ 0.34 - $ 0.37
$ 0.28 - $ 4.30
1,064,449
na
8.82M
$ 1.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 03-06-2025 01-01-1970 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-01-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-14-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-12-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-17-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 03-04-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 03-03-2020 12-31-2019 10-K
24 10-31-2019 09-30-2019 10-Q
25 08-01-2019 06-30-2019 10-Q
26 05-02-2019 03-31-2019 10-Q
27 02-28-2019 12-31-2018 10-K
28 11-07-2018 09-30-2018 10-Q
29 08-01-2018 06-30-2018 10-Q
30 05-09-2018 03-31-2018 10-Q
31 03-28-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

vyne-therapeutics-q2-eps-013-beats-022-estimate-sales-69000k-miss-150000k-estimate
VYNE Therapeutics Q2 EPS $(0.13) Beats $(0...
08/14/2025 12:05:02

VYNE Therapeutics (NASDAQ:VYNE) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0...

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
08/04/2025 12:08:38

gold-gains-1-wingstop-shares-spike-higher
Gold Gains 1%; Wingstop Shares Spike Higher
07/30/2025 18:40:34

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/30/2025 17:07:24

hc-wainwright--co-downgrades-vyne-therapeutics-to-neutral
HC Wainwright & Co. Downgrades VYNE Therap...
07/30/2025 15:20:26

HC Wainwright & Co. analyst Joseph Pantginis downgrades VYNE Therapeutics (NASDAQ:VYNE) from Buy to Neutral.

us-stocks-edge-higher-kraft-heinz-earnings-top-views
US Stocks Edge Higher; Kraft Heinz Earning...
07/30/2025 14:16:46

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/30/2025 12:08:36

vyne-therapeutics-announces-phase-2b-trial-with-repibresib-gel-in-nonsegmental-vitiligo-did-not-meet-primary-endpoint-or-key-secondary-endpoint-of-f-vasi50-and-f-vasi75
VYNE Therapeutics Announces Phase 2b Trial...
07/30/2025 12:08:09

Trial Did Not Meet Primary Endpoint or Key Secondary Endpoint of F-VASI50 and F-VASI75Nominally Statistically Significant Effec...

trading-halt-halted-at-75026-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:26 a.m. ET - ...
07/30/2025 11:50:30

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/17/2025 21:06:00

vyne-therapeutics-issues-program-update-for-vyn202-following-clinical-hold-issued-by-fda-in-april-for-phase-1b-clinical-trial-in-treatment-of-moderate-to-severe-plaque-psoriasis
VYNE Therapeutics Issues Program Update Fo...
07/02/2025 11:51:25

VYNE Therapeutics Inc. (NASDAQ:VYNE) ("VYNE" or the "Company"), a clinical-stage biopharmaceutical company focu...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
06/25/2025 17:06:36

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
06/04/2025 12:08:36

vyne-therapeutics-q1-eps-020-beats-029-estimate-sales-20200k-beat-5000k-estimate
VYNE Therapeutics Q1 EPS $(0.20) Beats $(0...
05/08/2025 12:06:05

VYNE Therapeutics (NASDAQ:VYNE) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
04/25/2025 17:06:15

fda-puts-vyne-therapeutics-early-stage-psoriasis-study-on-hold
FDA Puts VYNE Therapeutics Early-Stage Pso...
04/25/2025 15:55:30

VYNE pauses VYN202 psoriasis trial after FDA clinical hold tied to animal toxicity data; separate vitiligo trial remains on tra...

hc-wainwright--co-maintains-buy-on-vyne-therapeutics-lowers-price-target-to-45
HC Wainwright & Co. Maintains Buy on VYNE ...
04/25/2025 14:14:26

HC Wainwright & Co. analyst Joseph Pantginis maintains VYNE Therapeutics (NASDAQ:VYNE) with a Buy and lowers the price t...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
04/25/2025 12:09:07

fda-places-clinical-hold-on-vyne-therapeutics-phase-1b-study-for-vyn202-following-safety-concerns
FDA Places Clinical Hold On VYNE Therapeut...
04/25/2025 12:07:01

BRIDGEWATER, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (NASDAQ:VYNE) ("VYNE" or the "Company&...

vyne-therapeutics-to-present-at-autoimmune--inflammatory-disease-virtual-conference-march-27
Vyne Therapeutics To Present At Autoimmune...
03/20/2025 12:04:10

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION